Incyte Corporation has raised its full-year 2026 Opzelura net sales guidance to between $1.05 billion and $1.1 billion following a landmark settlement with the Centers for Medicare & Medicaid Services. The agreement
Samsung Biologics (KRX: 207940) has announced plans to acquire Swiss peptide manufacturer PolyPeptide in a deal worth approximately $1.8 billion, marking a landmark moment for South Korean biopharma. The transaction is described
More
The House Energy and Commerce Committee has advanced a sweeping package of health legislation, including an amended version of the Lower Costs, More Transparency Act, toward the House floor. The markup considered
More
UK equity markets pushed higher on Friday after retail sales data comfortably beat expectations, providing a domestic boost amid escalating geopolitical risks. The FTSE 100 gained 0.32% by 03:27 ET, while Germany’s
More
Oracle Corporation (NYSE: ORCL) has caught the attention of prominent market commentator Jim Cramer, who has singled out the stock as one investors should be monitoring closely. Cramer, known for his influential
More
Insurance broker Gallagher had organised cover for one of two tankers struck by Houthi missile attacks in the Red Sea last week, City AM has learned. The Lloyd’s of London broker, one
More
Businesses across industries are increasingly using skill-based contests to engage customers, reward loyalty, generate leads, and create new revenue streams. Executives often assume that labelling an activity a “skill contest” is enough
More
Law firms looking to grow their client base can benefit significantly from deploying free tools designed to capture leads at the earliest stages of their marketing funnel. These tools serve a dual
More
Wall Street faces a demanding week ahead as investors navigate a Federal Reserve interest rate decision alongside a surge of high-profile corporate earnings reports. The convergence of monetary policy signals and major
More
Hargreaves Lansdown, one of the UK’s largest investment platforms, regularly publishes its weekly stock market preview to help investors prepare for key events. The weekly outlook is a widely followed guide among
More
Merck (NYSE: MRK) has unveiled a sweeping access strategy for alimatravir, an investigational once-monthly oral pill designed to prevent HIV-1 infection. The drug, also known as MK-8527, is being positioned as a
More